Publications by authors named "David Upmalis"

Claim this Profile
B
Bowel function after tapentadol and oxycodone immediate release (IR) treatment in patients with low back or osteoarthritis pain.
Winghan J Kwong, Geoffrey Hammond, David Upmalis, Akiko Okamoto, Min Yang

Clin J Pain· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post hoc analyses of data from a 90-day clinical trial evaluating the tolerability and efficacy of tapentadol immediate release and oxycodone immediate release for the relief of moderate to severe pain in elderly and nonelderly patients.
Gary Vorsanger, Jim Xiang, David Biondi, David Upmalis, Jacqueline Delfgaauw

Pain Res Manag· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and pharmacodynamic modeling of opioid-induced gastrointestinal side effects in patients receiving tapentadol IR and oxycodone IR.
Xu Steven Xu, Mila Etropolski, David Upmalis, Akiko Okamoto, Rachel Lin

Pharm Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain relief and tolerability balance of immediate release tapentadol or oxycodone treatment for patients with moderate to severe osteoarthritis or low back pain.
Shane Kavanagh, W Jackie Kwong, Geoffrey C Hammond, Winnie Nelson, David Upmalis

Pain Med· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-response relationship after single oral dose administrations of morphine and oxycodone using laser-evoked potentials on UVB- and capsaicin-irritated skin in healthy male subjects.
Eef Hoeben, Johan W Smit, David Upmalis, Sarah Rusch, Klaus Schaffler

Pain· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of study discontinuations with tapentadol inmmediate release and oxycodone immediate release in patients with low back or osteoarthritis pain.
Gary Vorsanger, Jim Xiang, Akiko Okamoto, David Upmalis, Bruce Moskovitz

J Opioid Manag· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tapentadol immediate release: a new treatment option for acute pain management.
Marc Afilalo, Jens-Ulrich Stegmann, David Upmalis

J Pain Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of acetaminophen, naproxen, and acetylsalicylic acid on tapentadol pharmacokinetics: results of two randomized, open-label, crossover, drug-drug interaction studies.
Johan W Smit, Charles Oh, Jens Rengelshausen, Rolf Terlinden, Paulien G M Ravenstijn, David Upmalis

Pharmacotherapy· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tapentadol hydrochloride: a next-generation, centrally acting analgesic with two mechanisms of action in a single molecule.
Thomas M Tzschentke, Ulrich Jahnel, Babette Kogel, Thomas Christoph, Werner Englberger, David Upmalis

Drugs Today (Barc)· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain.
Stephen Daniels, Ed Casson, Jens-Ulrich Stegmann, Charles Oh, Akiko Okamoto, David Upmalis

Curr Med Res Opin· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study.
Martin Hale, David Upmalis, Akiko Okamoto, Claudia Lange, Christine Rauschkolb

Curr Med Res Opin· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain.
Stephen E Daniels, David Upmalis, Akiko Okamoto, Claudia Lange, Jüergen Häeussler

Curr Med Res Opin· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
Craig Hartrick, Ilse Van Hove, Jens-Ulrich Stegmann, Charles Oh, David Upmalis

Clin Ther· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and tolerability of multiple-dose tapentadol immediate release for the relief of acute pain following orthopedic (bunionectomy) surgery .
Jens-Ulrich Stegmann, Horst Weber, Achim Steup, Akiko Okamoto, David Upmalis

Curr Med Res Opin· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioavailability study of a 1200 mg miconazole nitrate vaginal ovule in healthy female adults.
Ruth E Stevens, Julraht Konsil, Sonya S Verrill, Partha Roy, Pankaj B Desai, David H Upmalis

J Clin Pharmacol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis